长期致力于动脉粥样硬化诊疗和人工心脏瓣膜等相关领域生物医用材料及器械的研究。作为负责人承担国家重点研发计划课题、四川省重大科技专项、国家自然科学基金项目等10余项国家及省部级基金项目。已在Advanced Materials、Biomaterials、ACS Nano等期刊发表论文59篇。申请国内外发明专利35项，授权23项。成果获四川省科学技术进步奖一等奖，四川大学科技进步二等奖。担任中国生物材料学会心血管材料分会委员，中国高科技产业化研究会医工融合产业工作委员会青年委员，Frontiers in Bioengineering and Biotechnology期刊副主编，Research期刊青年编委等。入选四川省学术与技术带头人后备人选，四川大学青年科技领军人才。

主要研究方向：1）动脉粥样硬化诊疗研究；2）生物心脏瓣膜新型交联方式和新型生物心脏瓣膜材料开发；3）新型抗心衰生物材料开发。

招生专业：生物医学工程，材料科学与工程，高分子化学与物理，有机化学，生物与医药，材料与化工

Dr Gaocan Li has long been engaged in the research on biomedical materials and devices for the diagnosis and treatment of atherosclerosis, artificial heart valves, and related fields. As the principal investigator, he has led over 10 national and provincial-level research projects in recent years, including the National Key R&D Program, Sichuan Major Science and Technology Special Project, and National Natural Science Foundation of China. He has published 59 papers in journals such as Advanced Materials, Biomaterials, and ACS Nano, and applied for 35 national and international patents, with 23 granted. Achievements have been awarded the First Prize of Sichuan Provincial Science and Technology Progress Award and the Second Prize of Sichuan University Science and Technology Progress Award. He serves as a member of the Cardiovascular Materials Branch of the Chinese Society for Biomaterials, a young committee member of the Medical-Engineering Integration Industry Working Committee of the China High-Tech Industrialization Research Association, Associate Editor of Frontiers in Bioengineering and Biotechnology, and Young Editorial Board Member of Research. He has been selected as a reserve candidate for Sichuan Provincial Academic and Technical Leading Talents and a ‌young technological leading talent of Sichuan University.

Main Research Directions:‌ 1) Diagnosis and treatment of atherosclerosis; 2) Development of novel crosslinking methods and biomaterials for bioprosthetic heart valves; 3) Development of novel biomaterials for heart failure treatment.